Evaluation of Dengue NS1 Antigen Rapid Tests and ELISA Kits Using Clinical Samples
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Early diagnosis of dengue virus (DENV) infection can improve clinical outcomes by ensuring close follow-up, initiating appropriate supportive therapies and raising awareness to the potential of hemorrhage or shock. Non-structural glycoprotein-1 (NS1) has proven to be a useful biomarker for early diagnosis of dengue. A number of rapid diagnostic tests (RDTs) and enzyme-linked immunosorbent assays (ELISAs) targeting NS1 antigen (Ag) are now commercially available. Here we evaluated these tests using a well-characterized panel of clinical samples to determine their effectiveness for early diagnosis. METHODOLOGY/PRINCIPAL FINDINGS: Retrospective samples from South America were used to evaluate the following tests: (i) "Dengue NS1 Ag STRIP" and (ii) "Platelia Dengue NS1 Ag ELISA" (Bio-Rad, France), (iii) "Dengue NS1 Detect Rapid Test (1st Generation)" and (iv) "DENV Detect NS1 ELISA" (InBios International, United States), (v) "Panbio Dengue Early Rapid (1st generation)" (vi) "Panbio Dengue Early ELISA (2nd generation)" and (vii) "SD Bioline Dengue NS1 Ag Rapid Test" (Alere, United States). Overall, the sensitivity of the RDTs ranged from 71.9%-79.1% while the sensitivity of the ELISAs varied between 85.6-95.9%, using virus isolation as the reference method. Most tests had lower sensitivity for DENV-4 relative to the other three serotypes, were less sensitive in detecting secondary infections, and appeared to be most sensitive on Day 3-4 post symptom onset. The specificity of all evaluated tests ranged from 95%-100%. CONCLUSIONS: ELISAs had greater overall sensitivity than RDTs. In conjunction with other parameters, the performance data can help determine which dengue diagnostics should be used during the first few days of illness, when the patients are most likely to present to a clinic seeking care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global distribution and burden of dengue
Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., Drake, J. M., Brownstein, J. S., Hoen, A. G., Sankoh, O., et al. (2013) · Nature · doi:10.1038/nature12060 · Cited by 10,037 · cited 1×
“5 billion people are at risk for infection worldwide, with no vaccine or antiviral approved to reduce disease burden [1,2].”
THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL
CLOPPER, C. J., & PEARSON, E. S. (1934) · Biometrika · doi:10.1093/biomet/26.4.404 · Cited by 5,003 · cited 1×
“Confidence intervals for sensitivity and specificity were calculated using the Exact Binomial method [42].”
MethodLanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J., & Vorndam, A. V. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.545-551.1992 · Cited by 1,818 · cited 1×
“Numerous successful molecular assays have been developed that detect DENV nucleic acid within the acute phase of illness [13–17]; however, these RT-PCR or isothermal molecular detection systems have yet to transition from the laboratory to a point-of-care format.”
BackgroundSimmons, C. P., Farrar, J. J., van Vinh Chau, N., & Wills, B. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1110265 · Cited by 1,732
Libraty, D. H., Young, P. R., Pickering, D., Endy, T. P., Kalayanarooj, S., Green, S., Vaughn, D. W., Nisalak, A., Ennis, F. A., & Rothman, A. L. (2002) · The Journal of Infectious Diseases · doi:10.1086/343813 · Cited by 739 · cited 3×
“Furthermore, quantitative detection of NS1 may help predict the risk associated with DENV infection, as high NS1 levels have been found to correlate with dengue hemorrhagic fever (DHF) [21,23,29,30].”
BackgroundInnis, B. L., Nisalak, A., Nimmannitya, S., Kusalerdchariya, S., Chongswasdi, V., Suntayakorn, S., Puttisri, P., & Hoke, C. H. (1989) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1989.40.418 · Cited by 711 · cited 1×
“DENV IgM and IgG titers were determined by ELISA, as previously described [38,39].”
MethodAlcon, S., Talarmin, A., Debruyne, M., Falconar, A., Deubel, V., & Flamand, M. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.02.376-381.2002 · Cited by 686 · cited 1×
“Together, the magnitude and timing of NS1 levels in human clinical specimens makes it an attractive target for diagnostic assay development [20,22,24].”
BackgroundYoung, P. R., Hilditch, P. A., Bletchly, C., & Halloran, W. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1053-1057.2000 · Cited by 542 · cited 2×
“Together, the magnitude and timing of NS1 levels in human clinical specimens makes it an attractive target for diagnostic assay development [20,22,24].”
BackgroundAvirutnan, P., Punyadee, N., Noisakran, S., Komoltri, C., Thiemmeca, S., Auethavornanan, K., Jairungsri, A., Kanlaya, R., Tangthawornchaikul, N., Puttikhunt, C., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/500949 · Cited by 509 · cited 1×
“Furthermore, quantitative detection of NS1 may help predict the risk associated with DENV infection, as high NS1 levels have been found to correlate with dengue hemorrhagic fever (DHF) [21,23,29,30].”
BackgroundLibraty, D. H., Endy, T. P., Houng, H. H., Green, S., Kalayanarooj, S., Suntayakorn, S., Chansiriwongs, W., Vaughn, D. W., Nisalak, A., Ennis, F. A., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/340365 · Cited by 494 · cited 1×
“Furthermore, quantitative detection of NS1 may help predict the risk associated with DENV infection, as high NS1 levels have been found to correlate with dengue hemorrhagic fever (DHF) [21,23,29,30].”
BackgroundMicroevolution and virulence of dengue viruses
Rico-Hesse, R. (2003) · Advances in Virus Research · doi:10.1016/s0065-3527(03)59009-1 · Cited by 422
Santiago, G. A., Vergne, E., Quiles, Y., Cosme, J., Vazquez, J., Medina, J. F., Medina, F., Colón, C., Margolis, H., & Muñoz-Jordán, J. L. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002311 · Cited by 387 · cited 1×
“Numerous successful molecular assays have been developed that detect DENV nucleic acid within the acute phase of illness [13–17]; however, these RT-PCR or isothermal molecular detection systems have yet to transition from the laboratory to a point-of-care format.”
BackgroundFlamand, M., Mégret, F., Mathieu, M., Lepault, J., Rey, F. A., & Deubel, V. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.6104-6110.1999 · Cited by 352 · cited 2×
“Together, the magnitude and timing of NS1 levels in human clinical specimens makes it an attractive target for diagnostic assay development [20,22,24].”
BackgroundArboviral Etiologies of Acute Febrile Illnesses in Western South America, 2000–2007
Forshey, B. M., Guevara, C., Laguna-Torres, V. A., Cespedes, M., Vargas, J., Gianella, A., Vallejo, E., Madrid, C., Aguayo, N., Gotuzzo, E., et al. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000787 · Cited by 298
Self-citationHarris, E., Roberts, T. G., Smith, L., Selle, J., Kramer, L. D., Valle, S., Sandoval, E., & Balmaseda, A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.9.2634-2639.1998 · Cited by 271 · cited 1×
“Numerous successful molecular assays have been developed that detect DENV nucleic acid within the acute phase of illness [13–17]; however, these RT-PCR or isothermal molecular detection systems have yet to transition from the laboratory to a point-of-care format.”
BackgroundTy Hang, V., Minh Nguyet, N., The Trung, D., Tricou, V., Yoksan, S., Minh Dung, N., Van Ngoc, T., Hien, T. T., Farrar, J., Wills, B., et al. (2009) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000360 · Cited by 260
Duyen, H. T. L., Ngoc, T. V., Ha, D. T., Hang, V. T. T., Kieu, N. T. T., Young, P. R., Farrar, J. J., Simmons, C. P., Wolbers, M., & Wills, B. A. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir014 · Cited by 199 · cited 3×
“Furthermore, quantitative detection of NS1 may help predict the risk associated with DENV infection, as high NS1 levels have been found to correlate with dengue hemorrhagic fever (DHF) [21,23,29,30].”
BackgroundMaternal Antibody and Viral Factors in the Pathogenesis of Dengue Virus in Infants
Simmons, C. P., Chau, T. N. B., Thuy, T. T., Tuan, N. M., Hoang, D. M., Thien, N. T., Lien, L. B., Quy, N. T., Hieu, N. T., Hien, T. T., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/519170 · Cited by 198 · cited 1×
“, anti-DENV IgM) can enhance the sensitivity and specificity of dengue diagnosis through all stages of the disease [25–28].”
BackgroundKittigul, L., Pitakarnjanakul, P., Sujirarat, D., & Siripanichgon, K. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.04.006 · Cited by 192 · cited 1×
“Dengue-associated mortality can be reduced from 20–30% in severe cases to less than 1% with appropriate fluid replacement and supportive care, which is greatly facilitated by early diagnosis [5–7].”
BackgroundBlacksell, S. D. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/151967 · Cited by 167 · cited 1×
“multiple groups and our results are in broad agreement with previously published retrospective studies evaluating these test articles [48,49].”
ResultDuong, V., Ly, S., Try, P. L., Tuiskunen, A., Ong, S., Chroeung, N., Lundkvist, Å., Leparc-Goffart, I., Deubel, V., Vong, S., et al. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001244 · Cited by 152 · cited 1×
“5% (range: 2% for InBios ELISA to 26% for InBios RDT) more sensitive for detecting primary dengue infections compared with secondary infections, as has been reported by others [34,44].”
ResultRapid diagnostic tests for non-malarial febrile illness in the tropics
Chappuis, F., Alirol, E., D’Acremont, V., Bottieau, E., & Yansouni, C. P. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12154 · Cited by 104 · cited 1×
“multiple groups and our results are in broad agreement with previously published retrospective studies evaluating these test articles [48,49].”
ResultRamı́rez, A., Moros, Z., Comach, G., et al. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.07.022 · Cited by 80 · cited 7×
“DENV serotypes were identified using serotype-specific monoclonal antibodies (DENV-1: 15F3, DENV-2: 3H5; DENV-3: 5D4; DENV-4: 1H10).”
BackgroundInfluentialTan, C. H., Wong, P.-S. J., Li, M.-Z. I., Vythilingam, I., & Ng, L. C. (2011) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2010.0028 · Cited by 70
Detection of Dengue Virus NS1 Antigen in Infected Aedes aegypti Using a Commercially Available Kit
Voge, N. V., Sánchez-Vargas, I., Blair, C. D., Eisen, L., & Beaty, B. J. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0477 · Cited by 55 · cited 1×
“Recently, NS1 tests have also been reported to be effective for detecting DENV in vector populations [31,32].”
BackgroundA new quantitative RT-PCR method for sensitive detection of dengue virus in serum samples
Sadon, N., Delers, A., Jarman, R. G., Klungthong, C., Nisalak, A., Gibbons, R. V., & Vassilev, V. B. (2008) · Journal of Virological Methods · doi:10.1016/j.jviromet.2008.06.023 · Cited by 52 · cited 1×
“Numerous successful molecular assays have been developed that detect DENV nucleic acid within the acute phase of illness [13–17]; however, these RT-PCR or isothermal molecular detection systems have yet to transition from the laboratory to a point-of-care format.”
BackgroundOverview of Agreement Statistics for Medical Devices
Lin, L. (2007) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400701668290 · Cited by 49 · cited 1×
“Sensitivity, specificity, and agreement were calculated with reference to the ‘‘gold standard’’ reference methodology using widely accepted definitions [41].”
Method
Metadata
- Authors
- Pal, S., Dauner, A. L., Mitra, I., Forshey, B. M., Garcia, P., Morrison, A. C., Halsey, E. S., Kochel, T. J., & Wu, S.-J. L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-11-20
- Volume
- 9
- Issue
- 11
- Pages
- e113411
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2059874988
- Cited by
- 189
- References
- 27
- FWCI
- 11.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.